Dulaglutide Patient Reviews
Trulicity patient reviews: well-tolerated with easy pen design. Moderate weight loss (3-5%) as secondary benefit. What diabetes patients say.
Avg. rating
7.0-7.5/10
Top praise
Easy pen, mild side effects
Weight loss
3-5% (secondary)
Pen preference
Highest among GLP-1s
Primary use
Type 2 diabetes
Patient Satisfaction
Trulicity receives solid satisfaction ratings for diabetes management, averaging 7.0-7.5/10 on review platforms. The hidden-needle pen design is consistently praised as the easiest GLP-1 injection device. Patient satisfaction is highest among those using it primarily for blood sugar control rather than weight loss.
Common praise includes excellent A1C reduction, easy-to-use pen, once-weekly convenience, and mild side effects. Criticisms focus on modest weight loss compared to newer options and rising costs.
Weight Loss Expectations
Patients prescribed Trulicity for diabetes often experience 3-5% body weight loss as a secondary benefit. While this is less than weight-specific GLP-1 medications, patients frequently report it as a welcome bonus. Setting realistic expectations is important -- Trulicity is not a weight loss medication.
Patients who want more significant weight loss typically discuss switching to or adding a medication specifically approved for weight management.
Frequently Asked Questions
How much weight do people lose on Trulicity?
Trulicity typically produces 3-5% body weight loss as a secondary benefit of diabetes treatment. It is not FDA-approved for weight management, so if weight loss is your primary goal, discuss alternatives with your provider.
Is Trulicity worth it?
For type 2 diabetes management, Trulicity is well-regarded with good A1C reduction and excellent tolerability. For weight loss specifically, more effective options exist.
Compare diabetes and weight loss GLP-1 options
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Dulaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.